Article
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.
Environmental health perspectives - 1 Mar 1995
Smith C M, Wang X, Hu H, Kelsey K T
Abstract excerpt
Associations between the presence of a constitutional variant of delta-aminolevulinic acid dehydratase (ALAD-2) and lead concentrations in blood and bone, as well as between this allele and indices of kidney function, were investigated among 691 members of a construction trade union. The average blood lead level in this group was 7.78 micrograms/dl. No significant difference was observed in blood lead...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
